Aprea Therapeutics, Inc. (APRE)

NASDAQ: APRE · Real-Time Price · USD

0.4445

-0.0011 (-0.25%)

At close: Nov 11, 2026, 4:00 PM EST

0.4599

+0.0154 (3.46%)

Pre-market: Nov 12, 2026, 8:14 AM EST

Aprea Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	37.85	14.6	22.85	21.61	28.79	53.08
Cash & Short-Term Investments	37.85	14.6	22.85	21.61	28.79	53.08
Cash Growth	175.89%	-36.11%	5.75%	-24.94%	-45.76%	-
Prepaid Expenses	0.59	0.96	0.73	0.91	1.37	3.51
Total Current Assets	38.44	15.56	23.58	22.52	30.15	56.58
Property, Plant & Equipment	0.06	0.06	0.08	0.09	0	0.21
Other Long-Term Assets	0.31	0.31	0.32	0.04	-	0.03
Total Assets	38.81	15.93	23.98	22.65	30.16	56.82

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.26	0.71	1.35	1.67	0.84	1.77
Accrued Expenses	2.71	2.05	2.01	2.19	2.36	5.35
Current Portion of Leases	-	-	-	-	-	0.19
Current Unearned Revenue	-	-	-	0.53	-	-
Total Current Liabilities	3.97	2.76	3.36	4.39	3.2	7.32
Total Liabilities	3.97	2.76	3.36	4.39	3.2	7.32

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	390.04	356.71	350.97	335.64	330.06	241
Retained Earnings	-345.33	-333.64	-321.04	-308.08	-293.8	-181.13
Comprehensive Income & Other	-10.61	-10.63	-10.63	-10.61	-10.62	-10.36
Total Common Equity	34.11	12.44	19.31	16.95	25.64	49.51
Shareholders' Equity	34.84	13.17	20.62	18.26	26.95	49.51
Total Liabilities & Equity	38.81	15.93	23.98	22.65	30.16	56.82

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	-	-	-	-	0.19
Net Cash (Debt)	37.85	14.6	22.85	21.61	28.79	52.89
Net Cash Growth	175.89%	-36.11%	5.75%	-24.94%	-45.57%	-
Net Cash Per Share	1.16	2.23	4.15	5.97	17.37	49.69
Filing Date Shares Outstanding	14.19	11.45	5.49	5.43	3.73	1.06
Total Common Shares Outstanding	14.19	8.19	5.48	3.74	2.66	1.06
Working Capital	34.46	12.8	20.22	18.14	26.95	49.27
Book Value Per Share	2.40	1.52	3.52	4.54	9.66	45.97
Tangible Book Value	34.11	12.44	19.31	16.95	25.64	49.51
Tangible Book Value Per Share	2.40	1.52	3.52	4.54	9.66	45.97
Machinery	-	0.15	0.15	0.14	0.05	0.14

SEC Filings: 10-K · 10-Q